Brain training tailored to deficits may curb relapse and crime

NCT ID NCT06981351

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This trial tests whether matching cognitive training to a person's specific thinking deficits can improve real-world outcomes for incarcerated individuals with substance use disorders. Participants are assigned to one of two types of training—one targeting attention to context, the other targeting emotional control—either matched or mismatched to their deficit profile. The study uses brain scans and behavioral tasks to see if the right match reduces substance use, improves adjustment, and lowers the chance of reoffending after release.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Two types of cognitive remediation training: Attention to Context (ATC) training and Affective Cognitive Control (ACC) training
What this could lead to
If matching training to a person's specific cognitive deficit works, it could lead to more effective rehabilitation programs that reduce substance use and reoffending after prison.
What could go wrong
This is an early-stage trial, and the training may not produce lasting real-world improvements. The effects could be small or not generalize beyond the study setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTISOCIAL BEHAVIOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mind Research Network/Lovelace Biomedical Research Institute

    RECRUITING

    Albuquerque, New Mexico, 87106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.